Jennifer N. Choi MDAssociate Professor of Dermatology and Chief, Division of Oncodermatology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Dr. Jennifer Choi is Associate Professor of Dermatology and Chief of the Division of Oncodermatology at the Robert H. Lurie Comprehensive Cancer Center and Northwestern Department of Dermatology. Dr. Choi specializes in providing skin care for patients undergoing cancer treatment. Her expertise includes knowledge in recognizing and managing side effects from chemotherapy, including rashes, very dry skin, itching, nail and hair changes, cutaneous metastases, radiation dermatitis and other changes due to radiation, infections in immunosuppressed patients, and toxicities that may arise as a result of stem cell or solid organ transplantation, including graft-versus-host disease and advanced skin cancer. She directs the Inpatient Dermatology Consult service for the Cancer Center, as well as the comprehensive skin care and skin cancer surveillance program for high-risk patients and all cancer survivors. She also helps to oversee Northwestern Memorial’s extracorporeal photopheresis unit. Additionally, she is director of clinical research trials investigating the prevention and treatment of cancer therapy-related side effects.
Dr. Choi also specializes in treating patients with skin cancer, including melanoma, squamous cell carcinoma and basal cell carcinoma. She is Co-Leader of the Skin Disease Team at the Robert H. Lurie Comprehensive Cancer Center and an integral member of the Northwestern Melanoma Unit. As part of this Unit, she specializes in the use of non-surgical immunotherapy treatments including topical imiquimod and intralesional immunotherapies for melanoma. She works closely in a multidisciplinary fashion with medical oncologists, surgical oncologists, radiation oncologists, and dermatopathologists. For all skin cancer patients, she conducts rigorous screening skin examinations on a regular basis to detect skin cancers and sun damage to optimize prevention and therapy. She is experienced with surgical treatment of skin cancers, as well as non-surgical methods to treat skin cancer and precancerous lesions.
Recent Contributions to PracticeUpdate:
- Evaluation of a Comprehensive Skin Toxicity Program for Patients Treated With EGFR Inhibitors at a Cancer Center
- Inflammatory Eruptions Associated With Immune Checkpoint Inhibitor Therapy
- Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-PD-1 and Anti-PD-L1 Immunotherapy
- Doxycycline for Prevention of Erlotinib-Induced Rash in Patients With Non–Small Cell Lung Cancer After Failure of First-Line Chemotherapy